FINWIRES · TerminalLIVE
FINWIRES

Jarden Lifts Forecasts on Reliance Worldwide's Adjusted EBITDA Fiscal 2027, 2028

By

Jarden increased its forecasts for Reliance Worldwide's (ASX:RWC) fiscal 2027 and fiscal 2028 adjusted earnings before interest, taxes, depreciation, and amortization (EBITDA), according to a Tuesday note by the investment firm.

The investment firm now expects Reliance Worldwide's adjusted EBITDA to be AU$287.3 million for fiscal 2027, up AU$2.9 million from its prior projection, and AU$320.3 million for fiscal 2028, up AU$8.8 million from previous its estimate.

The increase in the fiscal 2027 estimate reflects the announced closures and an expected second-half weighted EBITDA benefit impact, while the fiscal 2028 estimate reflects a AU$18.2 million increase across Americas, Jarden said.

Reliance Worldwide decided to exit Australian brass manufacturing as part of a multi-year effort to rationalize its manufacturing footprint. The closures reflect volume declines at the Melbourne facilities, driven by migration of SharkBite Max production to the firm's Alabama facility and the 2025 transition to third-party Asian sourcing for Asia-Pacific.

Jarden maintained an overweight rating on Reliance Worldwide and raised the price target to AU$4.10 from AU$4.

Reliance Worldwide's shares jumped past 4% in recent Wednesday trade.

Related Articles

Asia

Tetratherix Joint Venture Gets Ethics Approval for Clinical Trial of Hydrogel Spacer in Cancer Treatments

Tetratherix (ASX:TTX) said its Tutelix joint venture received ethics committee approval to launch a clinical trial for hydrogel spacer in Australia, according to a Tuesday filing with the Australian bourse.The Tutelix hydrogel spacer is used during cancer treatments to protect healthy parts of the body from damage.Positive six-month follow-up data confirms an opportunity for the product beyond the prostate cancer program, providing the company with a technical basis to pursue a gynaecological cancer indication, Tetratherix Chief Technology Officer Ali Fathi said.The clinical study has completed enrolment of all 15 patients across multiple Australian sites, per the filing.

ASX:TTX
Asia

Bharat Electronics Bags New Orders Worth INR10.8 Billion

Bharat Electronics (NSE:BEL, BOM:500049) has secured additional orders worth 10.8 billion Indian rupees within one month, according to a filing to the Indian stock exchanges on Monday.Major orders received since May 25 include communication equipment, radars, CBRN protection systems, seekers, avionics, upgrades, spares, and services, among others.

BOM:500049NSE:BEL
Asia

Chasen Secures Solar, EV Contracts in India

Chasen 9 (SGX:5NV) secured around 470 million Indian rupees worth of solar energy and electric vehicle battery contracts in India, according to a Monday filing with the Singapore Exchange.The deals include an electronics manufacturing services contract for specialist relocation services and an integrated solar manufacturing facility contract commissioned at the Reliance Industries' Dhirubhai Ambani Green Energy Giga Complex in Gujarat.

SGX:5NV